Enolase 1 (ENO1), MUC1, survivin, and VEGFR-2-targeting DNA vaccines are examples of the DNA-based pancreatic cancer vaccines explored so far [91–95]. This evidence concerns the gene MUC1 and pancreatic neoplasm.